123 related articles for article (PubMed ID: 29459063)
1. Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication.
Marosi A; Forgách P; Gyuranecz M; Sulyok KM; Bakonyi T
Vaccine; 2019 Aug; 37(33):4663-4672. PubMed ID: 29459063
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis.
Yamada K; Noguchi K; Kimitsuki K; Kaimori R; Saito N; Komeno T; Nakajima N; Furuta Y; Nishizono A
Antiviral Res; 2019 Dec; 172():104641. PubMed ID: 31672666
[TBL] [Abstract][Full Text] [Related]
3. Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus.
Anindita PD; Sasaki M; Okada K; Ito N; Sugiyama M; Saito-Tarashima N; Minakawa N; Shuto S; Otsuguro S; Ichikawa S; Matsuda A; Maenaka K; Orba Y; Sawa H
Antiviral Res; 2018 Jun; 154():1-9. PubMed ID: 29601893
[TBL] [Abstract][Full Text] [Related]
4. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin.
Marosi A; Dufkova L; Forró B; Felde O; Erdélyi K; Širmarová J; Palus M; Hönig V; Salát J; Tikos R; Gyuranecz M; Růžek D; Martina B; Koraka P; Osterhaus ADME; Bakonyi T
Vaccine; 2019 Aug; 37(33):4724-4735. PubMed ID: 29805091
[TBL] [Abstract][Full Text] [Related]
6. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
Yamada K; Noguchi K; Komeno T; Furuta Y; Nishizono A
J Infect Dis; 2016 Apr; 213(8):1253-61. PubMed ID: 26655300
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of ribavirin and favipiravir against human astroviruses.
Janowski AB; Dudley H; Wang D
J Clin Virol; 2020 Feb; 123():104247. PubMed ID: 31864069
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
10. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluating the effect of Favipiravir treatment on rabies virus infection.
Banyard AC; Mansfield KL; Wu G; Selden D; Thorne L; Birch C; Koraka P; Osterhaus ADME; Fooks AR
Vaccine; 2019 Aug; 37(33):4686-4693. PubMed ID: 29132993
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro.
Weiss RC; Oostrom-Ram T
Vet Microbiol; 1989 Jul; 20(3):255-65. PubMed ID: 2549687
[TBL] [Abstract][Full Text] [Related]
14. Selection of an aptamer against rabies virus: a new class of molecules with antiviral activity.
Liang HR; Hu GQ; Xue XH; Li L; Zheng XX; Gao YW; Yang ST; Xia XZ
Virus Res; 2014 May; 184():7-13. PubMed ID: 24486485
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir.
Smielewska A; Emmott E; Goodfellow I; Jalal H
J Clin Virol; 2018 May; 102():19-26. PubMed ID: 29477132
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds.
Crance JM; Gratier D; Guimet J; Jouan A
Res Virol; 1997; 148(5):353-65. PubMed ID: 9403935
[TBL] [Abstract][Full Text] [Related]
18. The effect of combined drugs therapy on the course of clinical rabies infection in a murine model.
Smreczak M; Orłowska A; Marzec A; Trębas P; Kycko A; Reichert M; Koraka P; Osterhaus ADME; Żmudziński JF
Vaccine; 2019 Aug; 37(33):4701-4709. PubMed ID: 29650384
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
[TBL] [Abstract][Full Text] [Related]
20. BCX4430 inhibits the replication of rabies virus by suppressing mTOR-dependent autophagy invitro.
Xie Y; Chi YL; Liu SQ; Zhu WY
Virology; 2023 Aug; 585():21-31. PubMed ID: 37267717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
